Real-world Data to Assess the Applicability of Randomized Controlled Trials in Newly Metastatic Prostate Cancer.
BACKGROUND Concerns persist regarding the applicability of randomized controlled trials (RCTs) on metastatic hormone-sensitive prostate cancer (mHSPC) to real-world clinical practice. OBJECTIVE We aimed to evaluate the generalizability of RCTs using data from PIONEER. DESIGN, SETTING AND PARTICIPANTS Trial eligibil...